Tumor-targeting anti-EGFR x anti-PD1 bispecific antibody inhibits EGFR-overexpressing tumor growth by combining EGFR blockade and immune activation with direct tumor cell killing
肿瘤靶向抗 EGFR x 抗 PD1 双特异性抗体通过结合 EGFR 阻断和免疫激活以及直接杀死肿瘤细胞来抑制 EGFR 过表达的肿瘤生长
期刊:Translational Oncology
影响因子:4.5
doi:10.1016/j.tranon.2020.100916
Li Li, Lan Deng, Xiaoqing Meng, Changling Gu, Li Meng, Kai Li, Xuesai Zhang, Yun Meng, Wei Xu, Le Zhao, Jianhe Chen, Zhenping Zhu, Haomin Huang
